There are a number of implications to pharmaceutical microbiology due to the Annex 1 revision. Because the Annex 1 revision outlines Contamination Control Strategy (CCS) requirements, many manufacturers may find their programs to be coming up short. For example, there is an expectation to trend both microbial and non-viable particle monitoring, ...
read more